1/16
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai | Chat |
|---|
No analytics yet
Send a link to your students to track their progress
Irreversible inhibition
Inhibitor covalently modifies the enzyme, disrupting the binding site and eliminating enzyme activity.
Reversible inhibition
Inhibition in which the inhibitor binds reversibly to the enzyme.
Competitive inhibitor
Binds reversibly to the active site of enzymes.
Competitive inhibition: complex formed
Forms a nonproductive enzyme-inhibitor complex (EI).
Competitive inhibition: substrate relationship
Substrate and inhibitor compete for binding to the active site.
Competitive inhibition: KM
Increases KM because more [S] is needed to reach ½ Vmax.
Competitive inhibition: Vmax
No effect on Vmax.
Uncompetitive inhibitor
Binds reversibly to the enzyme-substrate complex.
Uncompetitive inhibition: complex formed
Forms a nonproductive enzyme-inhibitor complex (ESI).
Uncompetitive inhibition: KM and Vmax
Affects both KM and Vmax.
Noncompetitive inhibitor
Binds reversibly outside the active site of enzymes.
Noncompetitive inhibition: complex formed
Forms a nonproductive EI or ESI complex.
Noncompetitive inhibition: substrate relationship
Substrate and inhibitor bind independently to the enzyme.
Noncompetitive inhibition: Vmax
Lowers Vmax.
Noncompetitive inhibition: KM
No effect on KM.
Methotrexate
Competitive inhibitor of dihydrofolate reductase used as an anticancer drug.
Transition-state analog inhibitor
Competitive inhibitors can be modeled after the transition state because enzymes often have a higher affinity for the transition state.